The effects of high dose vitamin D supplementation as a nutritional intervention strategy on biochemical and inflammatory factors in adults with COVID-19: Study protocol for a randomized controlled trial
Authors:
- Zahra KhorasanchiZKZahra Khorasanchi
- Payam SharifanPSPayam Sharifan
- Elahe HasanzadehEHElahe Hasanzadeh
- Mohammad Reza Shadmand Foumani MoghadamMMMohammad Reza Shadmand Foumani Moghadam
- Omid AhmadiOAOmid Ahmadi
- Reyhaneh EbrahimiREReyhaneh Ebrahimi
- Nasrin MilaniNMNasrin Milani
- Reza RezvaniRRReza Rezvani
- Hasan VatanparastHasan Vatanparast
Open Access
- 24 March 2022
- journal article
- research article
- Published by SAGE Publications in Nutrition and Health
- Vol. 28 (3) , 311-317
Abstract
Introduction: Low serum vitamin D has been shown to be a risk factor for Coronavirus 2019 (COVID-19). The aim of this study was to assess the effects of high dose vitamin D supplementation on hs-CRP, ESR and clinical outcomes, including duration of hospitalization, quality of life and New York Heart Association (NYHA) Functional Classification, in adults with COVID-19. Methods: This double-blind, randomized control trial will be conducted on patients with RT-PCR and/or chest CT scan diagnosis of COVID-19 admitted in Imam Reza Hospital, Mashhad, Iran. Participants will be randomized into control and intervention groups based on randomization sampling. The intervention group will receive soft gel containing 50,000 IU vitamin D on the first day followed by 10,000 IU/day through a supplement drop daily for 29 days. The control group will receive 1000 IU vitamin D daily through supplement drop and a placebo soft gel. All participants will undergo laboratory assessment including inflammatory markers, serum 25)OH)D, complete blood count (CBC), liver and renal profile, lipid profile and erythrocyte sedimentation rate (ESR) at baseline and at day 30. The mortality rate will be recorded in both groups. Results: Data will be presented using descriptive statistics. Comparison of changes in study parameters over the study period will be performed using analysis of covariance adjusting for possible confounders. Conclusions: The findings of this will provide evidence on the effects of high dose vitamin D supplementation on inflammatory markers in hospitalized COVID-19 patients.Keywords
Funding Information
- Mashhad University of Medical Sciences (981873)
This publication has 32 references indexed in Scilit:
- Micronutrients as immunomodulatory tools for COVID-19 managementClinical Immunology, 2020
- Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemicMetabolism, 2020
- Vitamin D insufficiency as a potential culprit in critical COVID‐19 patientsJournal of Medical Virology, 2020
- COVID-19: don't neglect antimicrobial stewardship principles!Clinical Microbiology and Infection, 2020
- Treatment Considerations for COVID-19Mayo Clinic Proceedings, 2020
- Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?Frontiers in Immunology, 2020
- COVID-19 and vitamin D—Is there a link and an opportunity for intervention?American Journal of Physiology-Endocrinology and Metabolism, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Empirical Treatment and Prevention of COVID-19Infection & Chemotherapy, 2020
- The Short Form Health Survey (SF-36): Translation and validation study of the Iranian versionQuality of Life Research, 2005